Oncology is orphaned One way that pharmaceutical companies have mitigated these risks is to pursue orphan indications for products' initial launches. The Orphan Drug Act of 1983 grants special ...

A study in patients with solid tumors found that CRBSI is significantly linked to mortality in patients with PICCs, whereas CRT and CRLC are not significant risk factors.

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients ... please refer to the Risk Factors (“Facteurs de Risque") section of ...